Question 1

What is SIPONIMOD used for?

Accepted Answer

SIPONIMOD (brand name MAYZENT) is a S1P Receptor Modulator indicated for 1 INDICATIONS AND USAGE MAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease.

Question 2

How does SIPONIMOD work?

Accepted Answer

SIPONIMOD works through the following mechanism: 12.1 Mechanism of Action Siponimod is an S1P receptor modulator. Siponimod binds with high affinity to S1P receptors 1 and 5. Siponimod blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood. The mechanism by which siponimod exerts therapeutic effects in multiple sclerosis is unknown, but may involve reduction of lymphocyte migration into the central nervous system..

Question 3

What are the most common side effects of SIPONIMOD?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for SIPONIMOD. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is SIPONIMOD the same as MAYZENT?

Accepted Answer

MAYZENT is a brand name for SIPONIMOD. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

SIPONIMOD

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations